Development and Adaptation Activities Clause Samples

Development and Adaptation Activities a. STRATEC shall develop the Instrument in accordance with the Project Parameters. The Parties shall apply and assign personnel, equipment, supplies, and all other appropriate resources at their disposal to develop the Instrument. The Parties shall use their best efforts to cooperate and coordinate in connection with all design activities. b. The Parties intend that their activities pursuant to this Agreement will be divided into four phases, as follows: Phase 1, Instrument Specification and Project Planning; Phase 2, Design and Development; Phase 3, Verification of Design; Phase 4, Transition to Manufacturing.
View SourceView Similar (3)
Development and Adaptation Activities a. STRATEC shall develop the Panther in accordance with the Project Parameters. As outlined in the Project Parameters, the parties will share responsibility for the work elements included within the development program. The parties’ initial responsibilities for the work elements shall be as set forth in the Project Proposal, subject to change by action of the Steering Committee. The Parties shall apply and assign personnel, equipment, supplies, and all other appropriate resources at their disposal to develop the Panther. The Parties shall use their best efforts to cooperate and coordinate in connection with all design activities. STRATEC shall review and accept or reject development work performed by Gen-Probe such that STRATEC may make the commitments set forth in Sections 6.2 and 6.3(a) of this Agreement and STRATEC’S obligations pursuant to Sections 6.2 and 6.3(a) shall not be excused by the nature of any work performed by Gen-Probe. b. In connection with the performance of the development activities hereunder, STRATEC shall provide Gen-Probe with monthly written reports indicating the status and the timeline of the Panther project including the common project plan. Upon Gen-Probe’s request and at reasonable intervals, STRATEC shall provide Gen-Probe with additional interim reports. c. The parties intend that their activities pursuant to this Agreement will divided into three phases, as follows: Phase 1, Instrument Specification and Project Planning; Phase 2, Design and Development; Phase 3, Transition to Manufacturing. Phase 2 will be divided into two subparts, (a) and (b), for the design, assembly, and delivery of Prototype and Validation Instruments, respectively. 1. Phase 1 shall be completed no later than 6 months following the execution of this Agreement. Immediately upon completion of Phase 1, STRATEC shall provide Gen-Probe with written notice of completion, the revised Project Parameters, and the Phase 1 Summary described in Section 2.3(c). If Gen-Probe has not previously authorized the commencement of Phase 2 development activities, Gen-Probe shall have sixty (60) days from the delivery of STRATEC’s notice of Phase 1 completion to deliver such authorization to STRATEC. If Gen-Probe fails to deliver such authorization within the time allowed, STRATEC may terminate this Agreement in its sole discretion without any obligation to Gen-Probe. 2. Dates for the completion of P▇▇▇▇▇ ▇, ▇, ▇▇▇ ▇ ▇▇▇▇▇ ▇▇ established during Phase 1 in accordance with Sec...
View Source

Related to Development and Adaptation Activities

  • Collaboration activities 4.1 The Collaboration Suppliers will perform the Collaboration Activities and all other obligations of this Agreement in accordance with the Detailed Collaboration Plan. 4.2 The Collaboration Suppliers will provide all additional cooperation and assistance as is reasonably required by the Buyer to ensure the continuous delivery of the services under the Call-Off Contract. 4.3 The Collaboration Suppliers will ensure that their respective subcontractors provide all cooperation and assistance as set out in the Detailed Collaboration Plan.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection ▇▇▇▇▇; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Construction Activities Please list all major construction activities, both planned and completed, to be performed by Seller or the EPC Contractor. Activity EPC Contractor / Subcontractor Completion Date __/__/____ (expected / actual) __/__/____ (expected / actual)